Advisors Capital Management, LLC Pfizer Inc Transaction History

Advisors Capital Management, LLC

$5.73 Billion
Q2 2024

A detailed history of Advisors Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Advisors Capital Management, LLC holds 1,472,707 shares of PFE stock, worth $40.4 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

1,472,707

Previous 1,412,155 4.29%

Holding current value

$40.4 Million

Previous $39.2 Million 5.15%

% of portfolio

0.72%

Previous 0.72%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$25.26 - $29.6 $1.53 Million - $1.79 Million	60,552 Added 4.29%	1,472,707 $41.2 Million
Q1 2024 May 06, 2024	BUY	$25.89 - $29.73 $2.97 Million - $3.41 Million	114,779 Added 8.85%	1,412,155 $39.2 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $1.42 Million - $1.85 Million	-54,364 Reduced 4.02%	1,297,376 $37.4 Million
Q3 2023 Nov 15, 2023	BUY	$32.09 - $37.51 $3.91 Million - $4.57 Million	121,963 Added 9.92%	1,351,740 $44.8 Million
Q2 2023 Aug 03, 2023	BUY	$36.12 - $41.79 $8.63 Million - $9.99 Million	238,974 Added 24.12%	1,229,777 $45.1 Million
Q1 2023 May 04, 2023	BUY	$39.39 - $51.28 $5.02 Million - $6.53 Million	127,382 Added 14.75%	990,803 $40.4 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $2.43 Million - $3.17 Million	-58,256 Reduced 6.32%	863,421 $44.2 Million
Q3 2022 Nov 16, 2022	BUY	$43.76 - $53.42 $5.19 Million - $6.33 Million	118,535 Added 14.76%	921,677 $45.4 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $1.87 Million - $2.22 Million	40,161 Added 5.26%	803,142 $42.1 Million
Q1 2022 May 10, 2022	BUY	$45.75 - $56.69 $22.5 Million - $27.9 Million	492,224 Added 181.8%	762,981 $39.5 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $9.54 Million - $14.1 Million	230,779 Added 577.26%	270,757 $16 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $65,233 - $83,798	1,662 Added 4.34%	39,978 $1.72 Million
Q2 2021 Aug 02, 2021	BUY	$35.91 - $40.68 $138,612 - $157,024	3,860 Added 11.2%	38,316 $1.5 Million
Q1 2021 May 12, 2021	SELL	$33.49 - $37.77 $73,912 - $83,358	-2,207 Reduced 6.02%	34,456 $1.25 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $50,171 - $63,797	1,499 Added 4.26%	36,663 $1.35 Million
Q3 2020 Nov 05, 2020	SELL	$31.75 - $37.25 $38,385 - $45,035	-1,209 Reduced 3.32%	35,164 $1.29 Million
Q2 2020 Aug 18, 2020	SELL	$30.12 - $36.54 $430,444 - $522,193	-14,291 Reduced 28.21%	36,373 $1.19 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $1.32 Million - $1.88 Million	-48,714 Reduced 49.02%	50,664 $1.65 Million
Q4 2019 Jan 10, 2020	BUY	$32.92 - $37.36 $1.39 Million - $1.58 Million	42,273 Added 74.03%	99,378 $3.89 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $310,084 - $402,088	9,544 Added 20.07%	57,105 $2.05 Million
Q2 2019 Aug 15, 2019	SELL	$36.98 - $41.52 $59,426 - $66,722	-1,607 Reduced 3.27%	47,561 $2.06 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $111,562 - $122,570	-2,975 Reduced 5.71%	49,168 $2.11 Million
Q4 2018 Jan 17, 2019	BUY	$38.47 - $43.86 $1.22 Million - $1.39 Million	31,775 Added 156.0%	52,143 $2.28 Million
Q3 2018 Oct 10, 2018	BUY	$34.47 - $41.81 $161,905 - $196,381	4,697 Added 29.97%	20,368 $898,000
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $83,736 - $89,271	-2,539 Reduced 13.94%	15,671 $569,000
Q1 2018 May 10, 2018	BUY	$31.91 - $37.02 $18,124 - $21,027	568 Added 3.22%	18,210 $646,000
Q4 2017 Jan 24, 2018	BUY	$33.26 - $35.29 $41,375 - $43,900	1,244 Added 7.59%	17,642 $639,000
Q3 2017 Oct 23, 2017	BUY	$31.0 - $34.15 $508,338 - $559,991	16,398	16,398 $585,000

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisors Capital Management, LLC with notifications on news.

Account

Advisors Capital Management, LLC Pfizer Inc Transaction History